Unfair older patients restriction in cancer drug trials in mainland China and corresponding solution

BACKGROUND: Older adults are a growing segment of oncology population in China and beyong. However, older cancer patients were vastly underrepresented in clinical trial. To facilitate that all patients with cancer have equal access to the cutting edging treatment and receive evidence-based medicatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Huiyao, Tang, Yu, Wu, Dawei, Meng, Xinyu, Wang, Shuhang, Wang, Jun, Yu, Yue, Fang, Yuan, Fang, Hong, Zhu, Qi, Li, Ning, Xu, Binghe, Sun, Yan, He, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064764/
https://www.ncbi.nlm.nih.gov/pubmed/36997858
http://dx.doi.org/10.1186/s12877-023-03886-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064764/
https://www.ncbi.nlm.nih.gov/pubmed/36997858
http://dx.doi.org/10.1186/s12877-023-03886-2

Ejemplares similares